Efficient access to patients with renal impairment for drug safety study Last updated: 2023-02-03 03:36
Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria Last updated: 2023-02-03 03:36